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Vitamin D metabolitesThe aimwas to determine the intestinal Ca2+ absorption in type I diabetic rats after different times of STZ induc-
tion, as well as the gene and protein expression of molecules involved in both the transcellular and paracellular
Ca2+ pathways. The redox state and the antioxidant enzymes of the enterocytes were also evaluated in duode-
num from either diabetic or insulin-treated diabetic rats as compared to control rats. Male Wistar rats
(150–200 g) were divided into two groups: 1) controls and 2) STZ-induced diabetic rats (60 mg/kg b.w.). A
group of diabetic rats received insulin for ﬁve days. The insulin was adjusted daily to maintain a normal blood
glucose level. Five 5 d after STZ injection, there was a reduction in the intestinal Ca2+ absorption, which was
maintained for 30 d and disappeared at 60 d. Similar changes occurred in the GSH and ˙O2− levels. The protein ex-
pression ofmolecules involved in the transcellular pathway increased at 5 and 30 d returning to control values at
60 d. Their mRNA levels declined considerably at 60 d. The gene and protein expression of claudin 2 was upreg-
ulated at 30 d. Catalase activity increased at 5 and 30 d normalizing at 60 d. To conclude, type I D.m. inhibits the
intestinal Ca2+ absorption, which is transient leading to a time dependent adaptation and returning the absorp-
tive process to normal values. The inhibition is accompanied by oxidative stress. When insulin is administered,
the duodenal redox state returns to control values and the intestinal Ca2+ absorption normalizes.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
There is a great body of evidence that human type I Diabetesmellitus
(D.m.) is associated with alterations in Ca2+ homeostasis resulting in
hypercalciuria and reduced bonemass or osteopenia [1]. Hypercalciuria
can be rectiﬁed by insulin, but only partially if hormone treatment is de-
layed, an indication that some irreversible changes might occur at early
stages of diabetes [2]. The diabetic hypercalciuria in rats involves en-
hanced glomerular ﬁltration rate with raised urinary output, reduced
Ca2+ reabsorption, and impaired bone deposition. A reduction of extra-
cellular Ca2+-sensing receptor without alterations in other Ca2+se;CAT,catalase;SOD,superox-
CA1b, Ca2+-ATPase; VDR, vita-
ceptor potential cation channel
A, radio immuno precipitation
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losa de Talamoni).transport molecules were shown throughout the whole kidney section
in diabetic rats [1]. However, Western blot analysis has shown that
the protein expression of plasma membrane Ca2+-ATPase (PMCA1b)
and vitamin D receptor (VDR) was signiﬁcantly decreased in kidneys
from streptozotocin (STZ)-treated mice compared to that of controls
[3]. With regard to bone, diabetic patients not only show osteopenia
[4], but also increased risk of fractures [5,6] and delayed fracture healing
[7]. The adverse effects of D.m. on bone have been attributed to
insulinopenia, microangiopathy, and alterations in local factors regulat-
ing bone remodeling [8]. Serum calcium has been observed to be de-
creased [9], normal [10] or increased [11] in type I D.m. In other
words, Ca2+ homeostasis in the type I D.m. is quite controversial and
needs to be clariﬁed.
The intestine is another important organ involved not only in the
maintenance of Ca2+ homeostasis, but also in the proper mineralization
of bone preventing osteoporosis and osteoporotic fractures [12]. Earlier
studies have shown that diabetic patients have a normal [13], low [14]
or high [15] intestinal Ca2+ absorption. Hough et al. [11] have found dif-
ferences in the intestinal Ca2+ absorption and in hormonal response in
diabetic rats depending on the duration of diabetes (chronic versus
short). Since nutritional factors also alter the intestinal Ca2+ absorption
[16], the variability in the data on the cation transport in diabetic patients
or animals might be also due to differences in the diet composition.
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tinal Ca2+ absorption either in mammals or in birds [17]. As serum
levels of 1,25(OH)2D3 have been proved to be decreased in diabetic
humans and rats [18], the alteration in the intestinal Ca2+ absorption
has been associated with vitamin D status [11]. The intestinal Ca2+ ab-
sorption occurs via paracellular and transcellular pathways. Apparently,
calcitriol enhances both routes. The transcellular pathway involvesmol-
ecules such as the transient receptor potential cation channel V6
(TRPV6), located at the apical side of enterocytes, calbindin D9k in the
cytoplasm, and PMCA1b and Na+/Ca2+-exchanger (NCX1), both pro-
teins at the basolateral membranes [19]. The paracellular via is less
known and, apparently, some proteins that form the tight junctions,
such as claudin 2 (cldn 2) and claudin 12 (cldn 12), could be involved
in Ca2+ movements [20]. There is a lack of information on the time de-
pendent changes about the gene and protein expression of these mole-
cules when the D.m. is developing.
The intactness of intestinal redox state is essential to have anoptimal
intestinal Ca2+ absorption. We have demonstrated that normal levels
of intracellular glutathione (GSH) are important to maintain a proper
intestinal Ca2+ absorption [21–23]. Although oxidative stress in the
small intestine during diabetes has been reported in STZ-induced dia-
betic rats [24], there is no information about a possible relationship be-
tween the intestinal Ca2+ absorption and the oxidative damage and the
antioxidant status of the intestine.
The aim of this study was to determine the intestinal Ca2+ absorp-
tion in STZ-induced diabetic rats (type I D.m.) after a short and long last-
ing period of induction, as well as the gene and protein expression of
molecules involved in both the transcellular and paracelluar pathways
of Ca2+ transport. In addition, the redox state and the antioxidant enzy-
matic system of the enterocytes were evaluated in the duodenum from
either diabetic or insulin-treated diabetic rats as compared to control
rats.
2. Materials and methods
2.1. Chemicals
All chemicals were purchased from Sigma Aldrich Co (St Louis, MO,
USA) unless otherwise stated.
2.2. Animals
Eight-week-old male Wistar rats (150–200 g) were maintained at
20–25 °C on a 12 h light–12 h dark cycle, with access to water and
food ad libitum. Calcium content in the diet was 1 %, and vitamin D con-
tentwas about 1000 IU/kg of diet (GEPSAmouse-rat, Pilar, Buenos Aires,
Argentina). The animals were divided into two groups: 1) control rats,
and 2) STZ-induced diabetic rats. Rats from the second group received
a single intraperitoneal injection of STZ (60 mg/kg b.w. dissolved in
0.1 mol/L citrate, pH 4.5 solution), whereas the control rats were
injected with vehicle alone. After 3 days of STZ injection, the blood glu-
cose levels were measured by using a glucometer (AccuCheck; Roche,
Germany). The animals were considered diabetic when their blood glu-
cose values exceeded 250 mg/dL and glucose was detected in urine
(Multistix, Siemens Medical Solutions Diagnostics, Malvern, USA).
STZ-treated rats were sacriﬁced by cervical dislocation at 5, 30 or
60 days after induction. All experimental protocols followed the Guide
for the Care and Use of Laboratory Animals from the Medicine School
of the Universidad Nacional de Córdoba, Córdoba, Argentina. All efforts
weremade tominimize the number of animals used and their suffering.
2.3. Insulin-treated diabetic rats
Thirty days after STZ injection, a group of rats received daily insulin
therapy (Insulina Glargina, Lantus, Sanoﬁ-Aventis, Uruguay S.A.) via
subcutaneous injection for ﬁve days until they were sacriﬁced. Theinsulin dosage was adjusted daily to maintain blood glucose level in
the range of 100–200 mg/dL.
2.4. Serum biochemical determinations
Blood samples from rats were used for biochemical measurements.
Serum glucose (Glicemia enzimática AA), Ca (Ca-Color AA), P
(Fosfatemia UV-AA), and creatinine (Creatinina-enzimática AA) were
determined using kits from Wiener Laboratorios S.A.I.C. (Rosario,
Argentina), HbA1c and insulin were determined by Glycohemoglobin
Reagent (Teco Diagnostics, Anaheim, CA, USA) and Rat insulin ELISA
(Millipore, Billerica, MA, USA) respectively, according tomanufacturer’s
operating protocol. 1,25(OH)2D3 was determined by RIA (DiaSorin,
Saluggia, Italy) and 25(OH)D3 by ECLIA immunoassay (Modular Analyt-
ics E1701, Roche, Mannheim, Germany).
2.5. Intestinal Ca2+absorption
Rats were anesthetized with an intramuscular injection of ketamine
(50 mg/kg b.w.) and xylazine (10 mg/kg b.w.). One mmol/L CaCl2, con-
taining 1.85 × 105 Bq 45Ca2+, pH 7.2, was introduced into the lumen of
the ligated intestinal segment. After ten minutes, blood waswithdrawn
by cardiac puncture, centrifuged and the plasma 45Ca2+ was measured
in a liquid scintillation counter. Absorption was deﬁned as appearance
of 45Ca2+ in blood [21].
2.6. Alkaline phosphatase activity assay
Alkaline phosphatase (AP), E.C. 3.1.3.1., was measured in water ho-
mogenates (1:10) of intestinal mucosa using p-nitrophenyl phosphate
as substrate in 0.5 mol/L diethanolamine buffer pH 9.8. This was per-
formed by following an adaptation of Walter and Schütt method [25].
Enzyme activities are expressed in IU/mg of protein.
2.7. RNA isolation and analysis of pmca1b, ncx1, trpv6 and cldn 2 gene
expression by qRT-PCR
Total RNA isolationwas performedwith TRIZOL reagent according to
the manufacturer’s instructions (Invitrogen, Carlsbad, CA, USA). RNA
concentration and purity were determined by spectrophotometry.
Quantitative RT-PCR ampliﬁcation was performed in a thermocycler
(Quantitative PCR thermocycler StratageneMx 3000P, Agilent Technol-
ogies, Inc., Santa Clara, CA, USA). Ampliﬁcation mixture (total volume:
25 μL) contained 0.5 μg RNA, 0.3 μmol/L each primer, 0.4 μL of the dilut-
ed reference dye, 1.0 μL of reverse transcriptase (RT)/RNase block
enzymemixture and 12.5 μL of 2× Brilliant IISYBR Green QRT-PCRmas-
ter mix (Stratagene, Agilent Technologies, Inc., Santa Clara, CA, USA).
The following protocol was used: 1 cycle at 50 °C for 30 min., 1 cycle
at 95 °C for 10 min., 40 cycles as follows: denaturation at 95 °C for
30 s, annealing at 60 °C for 60 s and extension at 72 °C for 30 s. The
amount of PCR products formed in each cycle was evaluated on the
basis of SYBR Green ﬂuorescence. Cycle-to-cycle ﬂuorescence emission
readings were monitored and quantiﬁed using the DDCt method [26].
The amount of copy numbers of mRNA from each gene was normalized
relative to that of GAPDH. The primers sequences of the studied genes
are listed in Table 1.
2.8. Western blot analysis
Immunoblotting analysis of PMCA1b, NCX1, TRPV6, VDR and cldn 2
was performed in pools ofmucosa from two rat duodenae each. Suspen-
sionswere done in RIPA (radio immuno precipitation assay buffer) lysis
buffer (1% SDS, 1% Triton X-100, 0.5% sodium deoxycholate in PBS, con-
taining 1 PMSF and 1 mmol/L NaF), and then centrifuged. Afterwards,
proteins (100 μg) were denatured for 5 min. at 95 °C and separated
in 12% (w/v) SDS–polyacrylamide minigels for cldn 2 and VDR and in
Table 1
Sequences of speciﬁc primers used for RT-qPCR ampliﬁcation.
Gene Primer sequences (5'–3') Size of the PCR products
(bp)
ncx1 Forward: GTTGTGTTCGCTTGGGTTGC 163
Reverse: CGTGGGAGTTGACTACTTTC
pmca1b Forward: CGCCATCTTCTGCACAATT 109
Reverse: CAGCCATTGTTCTATTGAAAGTTC
trpv6 Forward: ATCCGCCGCTATGCAC 80
Reverse: AGTTTTTCTGGTCACTGTTTTTGG
cldn 2 Forward: GCTGCTGAGGGTAGAATGA 107
Reverse: GCTCGCTTGATAAGTGTCC
Gapdh Forward: AGTCTACTGGCGTCTTCAC 133
Reverse: TCATATTTCTCGTGGTTCAC
ncx1: Na+/Ca2+ exchanger; pmca1b: plasma membrane Ca2+-ATPase; trpv6: transient
receptor potential V6; cldn 2: claudin 2; gapdh: glyceraldehyde-3-phosphate
dehydrogenase.
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Gels containing the separated proteins were immersed in the transfer
buffer (25 mmol/L Tris–HCl, and 192 mmol/L glycine, 0.05% w/v SDS
and 20% v/v methanol) [28]. Nitrocellulose membranes (0.45 μm)
were blocked for 1.5 h with 2% w/v nonfat dry milk in 0.5 mol/L Tris-
buffered saline solution and incubated overnight at 4 °C with the
speciﬁc primary antibody at 1:1000dilution in each case. The antibodies
were: anti PMCA1b (human erythrocyte clone 5 F10 A7952 SIGMA Saint
Louis, MO, USA), anti-NCX1 monoclonal antibody PPS019 (R&D Sys-
tems, Minneapolis, MN, USA), anti-TRPV6 polyclonal antibody (L-15:
sc-31445 Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-VDR
polyclonal antibody (C-20: sc-1008 Santa Cruz Biotechnology, Santa
Cruz, CA, USA), and anti-cldn 2 monoclonal antibody (Invitrogen,
Carlsbad, CA, USA). After three washings, appropriate secondary bio-
tinylated antibodies were incubated at room temperature for 1 h.
Then, the blots were washed three times and streptavidin – biotin con-
jugate (Histostain-SP Broad Spectrum, Invitrogen CA, USA) was added.
Detectionwas performed using 3,3’-diaminobenzidine (DAB) as a chro-
mogen. Monoclonal antibody anti-GAPDH (clone GAPDH-71.1 Sigma–
Aldrich, St. Louis, MO, USA), was used to detect GAPDH as a marker to
normalize the relative expression of the other proteins. The band inten-
sities were quantiﬁed using an Image Capturer EC3 Imaging System,
LaunchVisionworksls software in order to obtain the relative expression
of proteins.
2.9. Total GSH determination
Total GSH content was also determined in supernatants from
intestinal homogenates using the glutathione disulﬁde reductase-5,5´-
dithiobis (2-nitrobenzoate) recycling procedure, as described else-
where [29]. The data are expressed in nmol/mg of protein.
2.10. Superoxide anion measurement
Mature enterocytes from the duodenal villus tip were isolated
as previously described [30]. Cellular viability was assayed by the
Trypan blue exclusion technique. Cells were washed twice with Hanks
buffer (137 mmol/L NaCl, 5.4 mmol/L KCl, 0.25 mmol/L Na2HPO4,
0.44 mmol/L KH2PO4, 1.3 mmol/L CaCl2, 1 mmol/L MgSO4, 4.2 mmol/L
NaHCO3, 6.24 mmol/L glucose, pH 7.4) and incubated with nitro blue
tetrazolium (NBT) (1mg/mL) at 37 °C for 1 h. The formazan precipitates
formed were dissolved in dimethylsulfoxide and quantiﬁed by spectro-
photometry at 560 nm. OD values are direct indicators of ˙O2− concentra-
tion in the samples [31].
2.11. Catalase and superoxide dismutase activities
All enzymes activities were assayed in supernatants of duodenal ho-
mogenates. Catalase (CAT), EC 1.11.1.6, and superoxide dismutase(Mg2+-SOD), EC 1.15.1.1, activities were performed in diluted aliquots
from the supernatants of intestinal homogenates (1:5). CAT activity
was assayed in 50 mmol/L potassium phosphate buffer pH 7.4 and
0.3 mol/L H2O2 [32]. Mg2+-SOD activity was determined in 1 μmol/L
EDTA, 50 mmol/L potassium phosphate buffer, pH 7.8, 13 mmol/L
methionine, 75 μmol/L NBT and 40 μmol/L riboﬂavin [33]. Enzyme
activities are expressed in U/mg of protein.
2.12. Statistical analysis
All data are expressed asmeans± SE. The results were evaluated by
one-way analysis of variance (ANOVA) and the Bonferroni’s test as a
post hoc test. Differences were considered statistically signiﬁcant
at p b 0.05. All the analyses were carried out by using SPSS software
(version 17.0) for Windows XP (SPSS, Inc., Chicago, IL, USA).
3. Results
3.1. Characterization of the diabetic rats
Table 2 shows that theweight loss in rats injectedwith STZ occurred
as early as 5 days after the injection. At all times studied, the diabetic
rats exhibited lower bodyweight than the respective control rats. As ex-
pected, the body weight increased over time in control animals as well
as in diabetic rats, but in less proportion in the latter group. Serum glu-
cose levels were always signiﬁcantly higher in diabetic rats than those
from the control rats. Serumglucose remained unchanged in the control
rats, whereas in the diabetic rats the values were gradually increased
after the STZ injection. Serum insulin decreased sharply 5 days after
STZ injection decreasing even more over time. The percentage of
HbA1c increased almost 50 % in diabetic rats as compared to control
rats; this difference was kept at all times. Serum Ca values were similar
between control and diabetic rats, as well as serum P and serum creat-
inine at different times (Table 2).
3.2. D.m. inhibits transiently the intestinal Ca2+ absorption
A considerable reduction in the intestinal Ca2+ absorption was trig-
gered by STZ after 5 days of induction as compared to that of the control
rats. The intestinal Ca2+ absorption remained low 30 days after STZ in-
jection in the diabetic rats, returning to the control values at 60 days
(Table 3).
3.3. D.m. alters the intestinal AP activity
As shown in Fig. 1, the activity of intestinal AP, a protein presumably
involved in the intestinal Ca2+ absorption, decreased 5 days after STZ
injection, continued low after 30 days and, then, increased reaching
higher values compared to the control rats one month later.
3.4. D.m. modiﬁes the gene and protein expressions of molecules involved
in the transcellular and paracellular pathways of the intestinal Ca2+
absorption and the VDR protein expression
The gene expression of proteins involved in the transcellular path-
way of the intestinal Ca2+ absorption, pmca1b, ncx1 and trpv6, decreased
signiﬁcantly 60 days after STZ injection. The gene expression of cldn 2, a
protein presumably involved in the paracellular pathway of the intesti-
nal Ca2+ absorption, was more than double in diabetic rats than that of
the control rats 30 days after STZ injection and later decreased (Table 4).
In contrast, the protein expression of PMCA1b, NCX1 and TRPV6 signiﬁ-
cantly increased either 5 or 30 days after STZ injection returning to the
control values at 60 days, except that of the TRPV6. Cldn 2 protein ex-
pression highly increased 30 days after STZ induction and normalized
30 days later (Fig. 2). VDR protein expression was enhanced at all
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Table 3
Intestinal calcium absorption in control and diabetic rats (STZ).
Days after induction Control STZ
nmol 45Ca2+/mL plasma
5 3.03 ± 0.13 1.22 ± 0.06*
30 3.07 ± 0.25 2.39 ± 0.11#
60 3.05 ± 0.25 3.09 ± 0.33
Values are expressed as means ± S.E from 10 rats for each experimental condition. STZ:
streptozotocin induced diabetic rats. *p b 0.001 vs corresponding control and 30 and
60 days after STZ injection, #p b 0.01 vs corresponding control.
389M. Rivoira et al. / Biochimica et Biophysica Acta 1852 (2015) 386–394different times after STZ injection, but in less proportion 60 days after
the induction (Fig. 2).
3.5. Diabetes triggers oxidative stress in the rat duodenum
Fig. 3 shows that STZ caused GSH depletion in mucosa from the rat
duodenum either 5 or 30 days after injection, being the values normal-
ized 30 days later. The mucosal levels of ˙O2− were highly increased
5 days after STZ injection, andprogressively decreased reaching the nor-
malization after 60 days. Similarly, duodenal CAT activity was enhanced
5 and 30 days after STZ injection and returned to control values at 60
days. Duodenal SOD activity did not change after STZ injection at any
time.
3.6. Insulin restores the intestinal Ca2+ absorption and the intestinal redox
state of the diabetic rats, but not the levels of serum vitamin D metabolites
The inhibition of the intestinal Ca2+ absorption caused 30 days after
STZ injection to rats was blunted by using a single daily injection of in-
sulin for 5 days. The same hormonal treatment normalizedGSH content,
CAT activity and ˙O2− levels (Fig. 4). The serum levels of 25OHD3 and
1,25(OH)2D3 were decreased by STZ injection at different times, and
remained low after insulin treatment for 5 days (Table 5).
Discussion
The present study demonstrates that the intestinal Ca2+ absorption
decreases by insulin deﬁcit in rats injected with STZ. The effect is rela-
tively rapid and transient leading to a time dependent adaptation,
which makes that the absorptive process returns to normal values.
The inhibitory effect on the intestinal Ca2+ absorption is accompanied
by redox changes that cause oxidative stress, which may alter the0
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Fig. 1. Intestinal alkaline phophatase activity fromduodenal sac of control and STZ induced
diabetic rats. Alkaline phosphatase was measured in water homogenates (1:10) of intes-
tinal mucosa using p-nitrophenyl phosphate as a substrate in 0.5 mol/L diethanolamine
buffer pH 9.8. Values represent means ± SE from nine rats for each experimental condi-
tion. *p b 0.05 vs the corresponding control, #p b 0.001 vs the corresponding control,
§p b 0.05 vs 5 and 30 days after STZ injection.
Table 4
Gene expression of pmca1b, ncx1, trpv6 and cldn 2, in control and STZ induced diabetic rats.
Days after induction pmca1b ncx1 trpv6 cldn 2
Control STZ Control STZ Control STZ Control STZ
5 1.00 ± 0.18 0.70 ± 0.08 1.00 ± 0.15 1.22 ± 0.08# 1.00 ± 0.17 0.79 ± 0.17 1.00 ± 0.11 0.87 ± 0.07
30 1.00 ± 0.20 0.87 ± 0.15 1.00 ± 0.20 0.82 ± 0.08 1.00 ± 0.18 0.86 ± 0.07 1.00 ± 0.01 2.53 ± 0.50*#
60 1.00 ± 0.27 0.35 ± 0.07*# 1.00 ± 0.09 0.66 ± 0.07* 1.00 ± 0.07 0.66 ± 0.09* 1.00 ± 0.01 0.64 ± 0.10*
Real time quantitative PCR analysis of rat duodenae mRNA expression levels. Gene expression levels represent the relativemRNA expression compared with the GAPDHmRNA (arbitrary
units). Values representmeans ± SE from 6 rats for each experimental condition. STZ: streptozotocin induced diabetic rats. *p b 0.05 vs the corresponding control, #p b 0.001 vs STZ from
the other induction times.
390 M. Rivoira et al. / Biochimica et Biophysica Acta 1852 (2015) 386–394duodenum permeability. When insulin is administered, the redox state
of the intestine returns to control values and the intestinal Ca2+ absorp-
tion is normalized, independently of vitamin D status.
The adaptability of the intestine to absorbmore or less Ca2+ accord-
ing to the physio-pathological conditions has been known for many140 kDa
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jection, #p b 0.001 vs 5 and 30 days after STZ injection, +p b 0.001 vs 5 and 60 days after STZ iyears [34,35]. However, the mechanisms of adaptation of intestinal
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Table 5
Serum calcidiol (25(OH)D3) and calcitriol (1,25(OH)2D3) levels from control, STZ induced diabetic rats and STZ + I.
Days after induction 25(OH)D3 (ng/mL) 1,25(OH)2D3 (pg/mL)
Control STZ STZ + I Control STZ STZ + I
5 7.64 ± 0.49 3.17 ± 0.09* 3.22 ± 0.10* n.d. n.d. n.d.
30 10.89 ± 1.16 4.25 ± 0.82* 3.13 ± 0.06* 115.00 ± 3.51 35.83 ± 7.92# 36.33 ± 0.88#
60 9.94 ± 0.74 4.53 ± 0.77* 3.45 ± 0.20* 98.33 ± 0.66 25.33 ± 7.12# 30.20 ± 0.40#
Values are expressed as means ± S.E from 4 rats for each experimental condition. STZ: streptozotocin induced diabetic rats, STZ + I: diabetic rats treated with insulin. *p b 0.01 vs the
corresponding control, #p b 0.001 vs the corresponding control. n.d.: not determined.
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anti-inﬂammatory response in order to protect the intestine from the
inﬂammatory cell inﬁltration, as suggested [37]. The protein expression
of PMCA1b, NCX1 and TRPV6, all proteins presumably involved in the
Ca2+ transcellular pathway, is increased either 5 or 30 days after STZ in-
jection returning to control values at 60 days, except that of the TRPV6.
The data are indicative of an adaptive mechanism to improve the intes-
tinal Ca2+ absorption for avoiding Ca2+ loss, which has been detected
60 days after STZ injection. The TRPV6 protein expression goes down
at 60 days, but it is still signiﬁcantly higher than that of the control
group, which could mean that the Ca2+entrance step needs more time
to be normalized than the Ca2+ exit step from enterocytes. Lee et al.
[39] have also found a signiﬁcant increase in the abundance of renal
calbindin D28k and TRPV5 in diabetic rats for the 2-week duration com-
pared to control group. Both proteins belong to the transcellular path-
way of Ca2+ reabsorption in rat kidney and the increment of them has
been proposed as a compensatory mechanism for the enhancement of
renal Ca2+ excretion. It has been also reported similar compensatory
upregulations of sodium and water transporters in uncontrolled D.m.
in rats [40,41].
The gene expression of PMCA1b, NCX1 and TRPV6 is not modiﬁed 5
or 30 days after STZ injection. However, the mRNA levels codifying for
these proteins decline considerably 30 days later, when the intestinal
Ca2+ absorption returns to normal values. Our data suggest that the
transient inhibition of intestinal Ca2+ absorption caused by diabetes in-
duction would trigger a compensatory mechanism as judged by an in-
crease in the protein expression of molecules involved in the intestinal
transcellular Ca2+ movement. This response could downregulate the
gene expression of those proteins to avoid an overproduction of the
molecules responsible for taking the cation from one pole to the other
pole within the cell. In other words, the transcription of these genes is
not altered by the insulin deﬁcit at early stages of diabetes, but the pro-
tein synthesis seems to be stimulated in order to rapidly compensate
the inhibition of the intestinal Ca2+ absorption.
Although themolecular basis for paracellular Ca2+ absorption in the
intestine is not well known [42], tight junction proteins cldn 2 and
cldn12 have been proposed to form the paracellular pores for cations
[20]. Our data on gene and protein expressions of cldn 2 showno chang-
es at 5 days after STZ injection. However, a sharp rise in the protein ex-
pression of cldn 2 occurs 30 days after STZ injection, which is also
accompanied by increased gene expression. It is quite possible that
the enhanced protein expression of molecules involved in the transcel-
lular pathway is not enough for restoring the intestinal Ca2+ absorption
and, consequently, the paracellular pathway is induced, a possible inter-
play of both mechanisms that has been previously suggested [19]. In
other words, the insulin deﬁcit promotes the transcellular and the
paracellular pathways of the intestinal Ca2+ absorption in order to nor-
malize the cation absorption.
As previously shown [43,44], the diabetic condition alters the vita-
min D metabolism, as judged by the low levels of serum calcidiol and
calcitriol. This could partly explain the inhibition in the intestinal Ca2+
absorption that occurs as early as 5 days after STZ injection, but not
the compensatory stimulation of molecules of both transcellular and
paracellular pathways. Therefore, other molecules could be responsiblefor the compensatory mechanisms. In addition, insulin replacement
therapy for 5 consecutive days does not improve the impaired vitamin
D metabolism. Maybe a longer insulin therapy or other factors are nec-
essary to normalize serum calcitriol levels.
The occurrence of oxidative stress in the small intestine has been
demonstrated in diabetic rats 6 weeks after STZ injection [24]. Our
study shows that oxidative stress is triggering in the duodenum at
early stages of STZ-induced diabetic rats as revealed by GSH depletion,
increased ˙O2− and increase in the CAT activity after 5 days of induction.
These alterations are also very noticeable at 30 days, but disappear
30 days later. There is a temporal correlation between changes in the in-
testinal Ca2+ absorption and the oxidative stress. The recovery of the
normal redox status of the enterocytes occurs at the same time that
the intestinal Ca2+ absorption returns to control values.When consecu-
tive insulin injections for 5 days are administered to rats 30 days after
STZ injection, the intestinal Ca2+ absorption is normalized as well as
the intestinal GSH content, the ˙O2− levels and the CAT activity. Therefore,
the lack of insulin promotes intestinal oxidative stress, which in turn
causes inhibition of intestinal Ca2+ absorption. In our laboratory we
have well documented that GSH depleting drugs such as menadione,
deoxycholate and BSO inhibit the intestinal Ca2+ absorption through
oxidative stress and apoptosismediated by both the extrinsic and intrin-
sic pathways [21–23]. In diabetic animals there are compensatory
mechanisms trying to normalize the redox state and, consequently,
the intestinal Ca2+ absorption. It is interesting to note that these mech-
anisms occur independently of the levels of plasma vitamin D metabo-
lites. However, we have shown that the intestinal VDR protein
expression is increased by the STZ injection at all times studied. This up-
regulation of VDR has been suggested as a unique compensatory re-
sponse of intestine in untreated D.m. animals, which has been
associated with the intestinal hyperplasia [45]. In addition, a higher af-
ﬁnity of calcitriol to intestinal VDR has been also demonstrated in type
I D.m [46].
Many studies indicate that oxidative stress plays a crucial role in the
pathogenesis of late diabetic complications [47,48]. It has been proved
that hyperplasia and hypertrophy of intestinal epithelial cells and de-
crease in ﬂuidity of the brush border membranes occur in the small in-
testine of diabetic rats 6 weeks after STZ injection [49], and a reduction
in the density of myenteric neurons of the duodenum was observed
120 days after STZ administration [50]. In the jejunum of diabetic rats
15 days after STZ injection, increase in the length of villi, congestion,
goblet cell hyperplasia and inﬁltration of inﬂammatory cells have been
found [38]. Our study shows that oxidative stress in the duodenum of
diabetic rats occurs at early stages, but if an appropriate compensatory
response occurs from the antioxidant network, the redox imbalance
can be overcome and the intestinal Ca2+ absorption returns to normal
values.We do not discard that transitory alterations in the intestinal ab-
sorption of other ions or nutrients could be also occurred.
To conclude, oxidative stress in the rat intestine occurs at early
stages of developing type I D.m., leading to inhibition of the intestinal
Ca2+ absorption. Time-dependent adaptive mechanisms trigger an in-
crement of protein expression of molecules involved in both the trans-
cellular and the paracellular pathways, normalizing the intestinal
Ca2+ absorption as well as the duodenal redox state. Insulin injection
393M. Rivoira et al. / Biochimica et Biophysica Acta 1852 (2015) 386–394also restores the duodenal redox state and the intestinal Ca2+ absorp-
tion without improving the serum levels of vitamin D metabolites. The
characterization of the intestinal Ca2+ absorption in diabetic animals
is an important issue that might help to understand the alterations in
the Ca2+ homeostasis and the bone disease associated with the type I
D.m. in humans.
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